Anesta was a U startup company that developed a successful product called Actiq, a breakthrough treatment for cancer pain based on the company's patented oral transmucosal system. The product is derived from the research of Dr. Theodore Stanley, professor of anesthesiology at the U. Cephalon bought Anesta in 2000 in an all-share deal worth $444 million. Cephalon was later purchased by Teva Pharmaceuticals in 2011. Teva is a global pharmaceutical company committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs. Headquartered in Israel, Teva has a global product portfolio of more than 1,300 molecules and a direct presence in about 60 countries. Learn more at www.actiq.com or www.tevapharm.com.